101 Results (Page 1 of 9)
Global Markets Research Reports
Global Diabetes Drugs Market Analysis
The global diabetes drugs market size was valued at $61.78 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $99.21Bn in 2030. The market is segmented by drug type, application, distribution channel, and geography. The global diabetes drug market will grow because the increasing prevalence of diabetes globally is creating a growing demand for effective diabetes treatments. The key market players are Johnson & Johnson, Bayer Pharmaceuticals, Novo Nordisk, Sanofi, Merck, Eli Lilly and Company, and others.
Global Robotic Surgery Services Market Analysis
The Global robotic surgery service market size was valued at $4.29 Bn in 2022 and is estimated to expand at a CAGR of 19.3% from 2022-30 and will reach $17.63 Bn in 2030. The advantages of robotic surgery and technological developments in surgical robots are the main drivers of the surgical robot market's expansion. The robotic surgery service market will grow due to robotic surgery technology having made complex surgical procedures more accessible, especially in rural areas where access to specialized surgeons may be limited. The market is segmented by product and service type, application type, and end user. Some of the major players the prominent players in the surgical robot market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic Plc (Ireland), Smith & Nephew (UK), and others.
Global Apheresis Market Analysis
The Global apheresis market is expected to witness growth from $3.6 Bn in 2022 to $6.4 Bn in 2030 with a CAGR of 8% for the forecasted year 2022-30. The major market drivers for the Global apheresis market include the increasing demand for blood and its product for the treatment of chronic diseases such as myasthenia gravis and familial hypercholesterolemia, etc. the market is segmented by product, by end-user, by component, and by geography. Fresenius Kabi, Terumo, and Haemonetics are some of the major competitors in the Global apheresis market.
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. Factors such as increasing research and development expenditure by biotechnology and pharmaceutical companies across the countries in the region and booming clinical trials coupled with drug approvals, especially in the United States, are driving the growth of the HEOR services market in North America.
Global Clinical Trial Patient Recruitment Services Market Analysis
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. Some key players in the global clinical trial patient recruitment services market include IQVIA, Parexel International, PRA Health Sciences, Syneos Health, and WCG Clinical. Other important players include ICON plc, Medpace, Charles River Laboratories, and Premier Research.
Global Real World Evidence (RWE) Solutions Market Analysis
The Global Real World Evidence (RWE) solutions market is projected to grow from $79.7 Bn in 2022 to $42.4 Bn by 2030, registering a CAGR of 8.2% during the forecast period of 2022-2030. AI and ML are being increasingly used in RWE solutions to analyze large amounts of data, identify trends, and generate insights. The major players in the RWE solutions market include IQVIA, Syneos Health, Parexel, Covance, and IMB, among others. These companies offer a range of RWE solutions and services to meet the needs of the industry.
Global Alzheimer’s Disease Drugs Market Analysis
Global Alzheimer’s disease drugs market was valued at $15.42 Bn in 2022 and is estimated to expand at a CAGR of 8.42% from 2022-30 and will reach $29.44 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
Global Clinical Diagnostics Market Analysis
The Global clinical diagnostic market was valued at $68.92 Bn in 2022 and is estimated to expand at a CAGR of 6% from 2022-30 and will reach $109.85 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America Holdings, DiaSorin, PerkinElmer, FUJIFILM Corporation, and others.
Global Patient Engagement Solutions Market Analysis
The Global patient engagement solutions market is projected to grow from $17.01 Bn in 2022 to $42.72 Bn by 2030, registering a CAGR of 12.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be the implementation of government locations and initiatives to promote patient-centric care. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Allscripts Healthcare, Orion Health, Cerner Corporation, McKesson, Athenahealth, IBM, Medecision, GetWellNetwork, Medhost, and Lincor.
Global HIV Therapeutics Market Analysis
The Global HIV therapeutics market is expected to reach $17.029 Bn by 2030, up from $13.76 Bn in 2022, with a CAGR of 2.7% from 2022 to 2030. Global players such as ViiV Healthcare, AbbVie, Janssen Pharmaceuticals, and Gilead Sciences dominate the Global HIV therapeutics market. The global government policies, funding, poverty, and initiatives by international organizations to manage HIV infections propel the market. The Global HIV therapeutics market is divided into five segments type, product, geography, end user, and distribution channel.
Global Neurology Devices Market Analysis
The Global Neurology Devices Market size was valued at $12.62 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.80% from 2022 to 2030 and will reach $23.01 Bn in 2030. The main factors driving the growth of the global neurology devices market are the rise in the elderly population around the world, the increased demand for minimally invasive procedures, and the rise in disposable income. The market is segmented by product type and by the end user. Some key players in this market include Abbott Laboratories, B. Braun, Boston Scientific, Integra Life Sciences, and Stryker.
Global Home Healthcare Market Analysis
The Global home healthcare market was valued at $362.64 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $667.75 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by component and indication. Some key players in this market are Koninklijke Philips N.V, F. Hoffmann-La Roche AG, A&D Company, Fresenius SE & Co KGaA, Abbott, GE Healthcare, McKesson Corporation, and others
Global Palliative Care Market Analysis
The Global Palliative care market is projected to grow from $13.08 Bn in 2022 to $24.21 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing number of patients with chronic illnesses, the rising incidence of infectious diseases, and technological advancements. The market is segmented by service type and by the end user. Some of the major players include Amedisys, Home Instead, Vitas Healthcare, Sunrise Senior Living Centers, Golden Living Centers, Seymour Health, Genesis HealthCare, and Kindred Healthcare.
Global Cancer Pain Management Market Analysis
The global Cancer Pain Management market is projected to grow from $6.52 Bn in 2022 to $9.86 Bn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-2030. The main factors driving the growth would be the aging population, rising cancer prevalence, rising healthcare costs, and rising R&D spending by various healthcare businesses. The market is segmented by drug type and by disease. Some of the major players include Aoxing Pharmaceutical, Pfizer, Grunenthal Pharma, Teva Pharmaceutical, Hisamitsu Pharmaceutical, Sanofi, Daiichi Sankyo, Orexo, WEX Pharmaceuticals, and Sorrento Therapeutics.
Global Bioinformatics Market Analysis
The Global Bioinformatics market is projected to grow from $15.35 Bn in 2022 to $51.37 Bn by 2030, registering a CAGR of 16.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be the demand for integrated data, more protein and nucleic acid sequencing due to lower sequencing costs, and increased proteomics and genomics applications. The market is segmented by technology and by application. Some of the major players include Thermo Fisher Scientific, Qiagen, IBM Life Sciences, Agilent Technologies, Illumina, and PerkinElmer.
Global Digital Health Market Analysis
The Global Digital Health market is projected to grow from $211 Bn in 2022 to $825.96 Bn by 2030, registering a CAGR of 18.6% during the forecast period of 2022 - 2030. The market will be driven by increased investment in digital health solutions and government initiatives to modernize healthcare systems. The market is segmented by solution, by deployment & by end-use. Some of the major players include Apple Inc., Cerner Corporation, and Philips Healthcare.
Global Breast Cancer Therapeutics Market Analysis
With an increase in breast cancer cases worldwide and rising investments in the research and development projects for breast cancer treatment, the Global breast cancer therapeutics market is expected to grow from $18.2 Bn in 2022 to $48.04 Bn in 2030 with a CAGR of 12.9% for the year 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. Some of the key market players in the Global breast cancer therapeutics market are Sanofi, Pfizer, and AstraZeneca.
Global Over The Counter (OTC) Pharmaceuticals Market Analysis
The global OTC Drugs market is projected to grow from $157.0 billion in 2021 to $233.6 billion in 2028 at a CAGR of 5.8% in forecast period, 2021-2028 owing to pharmaceutical companies switching from Rx to OTC drugs, especially in the U.S. and growing trend of self-medication in developing economies.
Global Electronic Health Records Market Analysis
The Global Electronic Health Record market size was valued at $2.27 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4% from 2022 to 2030 and will reach $38.71 Bn in 2030. Global EHR market growth can be attributed to the surging need for remote monitoring and chronic disease management. The market is segmented by product type, application type, and end user. The key market players are Cerner Healthcare, GE Healthcare, Allscripts Healthcare, and others.
Global Digital Therapeutics Market Analysis
The Global Digital Therapeutic Market is projected to grow from $3.88 Bn in 2022 to $17.248 Bn by 2030, registering a CAGR of 20.50% during the forecast period of 2022 - 2030. It is anticipated to expand due to the increasing adoption of digital health technologies, growing demand for remote patient monitoring, and rising incidence of chronic diseases. Some key players in the digital therapeutic market include Omada Health, Proteus Digital Health, and WellDoc.
Global Cardiovascular Drugs Market Analysis
The Global Cardiovascular Drug Market size is at around US $ 55.32 Bn in 2022 and is projected to reach US $78.791 Bn in 2030, exhibiting a CAGR of 4.52% during the forecast period. The rising public awareness of cardiovascular health and the associated rise in product introductions are two major factors contributing to the growth of the Global market for cardiovascular medications. Some of the biggest cardiovascular drug companies in the world are Pfizer Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, and Novartis AG.
Global Physiotherapy Market Analysis
The Global physiotherapy market size was valued at $15.35 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 16.3% from 2022 to 2030 and will reach $51.37 Bn in 2030. The Global physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an ageing population. The market is segmented by Product Type Application Type and End User. The major players in the Global physiotherapy market are PhysioGlobal, BTL, EMS Physio Ltd., Dynatronics Corporation, RICHMAR, and others.
Global ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
The global market for ADHD is estimated to be worth $29.56 Bn in 2022 and is projected to expand to $41.08 Bn by 2030, with a CAGR of 4.2% over the forecast period. According to statistics, the estimated total annual national healthcare expenses of ADHD in Europe was $356.14 Mn, while those in Asia were $53.16 Bn. The market segments by drug kinds, age groups, distribution methods, and type of psychotherapy are highlighted in the Insights10 report. Eli Lily and Co., Pfizer, Johnson & Johnson, and Lupin are the top companies controlling the global market.
Global Patient Support Programs (PSP) Market Analysis
The Global patient support program market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Factors driving this market include an aging population, the increasing prevalence of chronic diseases, and the rising cost of healthcare. The market is segmented by delivery type, component type, and therapeutic area, application type, end-user type. Some of the key players in the global patient support program market include Pfizer, Novartis, Roche, and Merck.
Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Global Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.